Skip to content

    TREACE MEDICAL CONCEPTS (TMCI) stock price & financials

    View TMCI earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance37.3% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $45.09M
    $68.71M
    $52.57M
    $47.39M
    $50.21M
    +11.4%
    $62.52M
    -9.0%
    $47.20M
    -10.2%
    $45.38M
    -4.2%
    Weakening
    Operating Profit
    -$15.13M
    -$204.0K
    -$15.58M
    -$16.97M
    -$15.68M
    -3.6%
    -$5.92M
    -2802.9%
    -$17.17M
    -10.2%
    -$14.96M
    +11.9%
    Weakening
    Net Profit
    -$15.36M
    -$501.0K
    -$15.92M
    -$17.40M
    -$16.29M
    -6.0%
    -$9.39M
    -1775.0%
    -$17.96M
    -12.8%
    -$15.87M
    +8.8%
    Weakening
    EPS
    $-0.25
    $-0.25
    $-0.28
    $-0.26
    -4.0%
    $-0.28
    -12.0%
    $-0.24
    +14.3%
    Stable
    Other Income
    Interest
    $1.31M
    $1.31M
    $1.31M
    $1.32M
    $1.34M
    +1.9%
    $1.35M
    +2.7%
    $1.57M
    +19.8%
    $1.56M
    +18.2%
    Strengthening
    Depreciation
    Profit before Tax
    MarginsOPM
    -33.6%
    -0.3%
    -29.6%
    -35.8%
    -31.2%
    +7.0%
    -9.5%
    -3056.7%
    -36.4%
    -22.7%
    -33.0%
    +8.0%
    Weakening
    Tax
    ReturnsROIC
    4.9%
    0.2%
    5.0%
    5.5%
    5.2%
    +6.0%
    3.0%
    +1775.0%
    5.7%
    +12.8%
    5.0%
    -8.8%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$12.14M$18.08M$105.83M$19.47M$12.98M$11.35M$10.71M$12.61M
    Short-Term Investments$0$61.78M$110.22M$64.33M$37.66M$33.01M
    Total Current Assets$40.98M$137.97M$133.40M$198.36M$161.40M$132.05M$120.45M
    Net PP&E$829.0K$2.85M$25.48M$31.56M$34.40M$37.37M$39.63M
    Goodwill$0$12.81M$12.81M$12.81M$12.81M
    Intangibles$0$9.03M$8.07M$7.13M$6.65M
    Total Assets$41.81M$140.82M$159.02M$251.91M$217.09M$190.58M$181.06M
    LiabilitiesTotal Current Liabilities$11.60M$18.21M$30.25M$45.03M$34.92M$30.64M$41.50M
    Short-Term Debt$1.79M$0$1.75M$3.17M
    Long-Term Debt$29.19M$29.36M$52.71M$53.01M$53.31M$55.58M$56.04M
    Long-Term Leases$0$15.54M$15.89M$15.93M$13.98M$13.09M
    Total Liabilities$41.03M$47.75M$98.50M$113.97M$104.20M$103.25M$113.32M
    EquityCommon Stock & APIC$45.0K$55.0K$62.0K$62.0K$64.0K$65.0K
    Retained Earnings-$21.35M-$41.91M-$84.72M-$134.25M-$189.99M-$248.99M-$282.83M
    Total Equity$3.16M$776.0K$93.07M$60.53M$137.94M$112.89M$87.33M$67.74M
    HighlightsNet Cash / (Debt)-$12.90M$22.37M-$8.96M-$13.59M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$7.67M-$4.49M-$17.19M-$30.65M-$34.58M-$37.17M-$15.97M-$14.58M
    Cash from Investing-$1.21M-$1.07M-$2.71M-$76.52M-$81.30M$35.38M$13.25M$17.65M
    Cash from Financing$19.74M$11.50M$107.65M$20.81M$109.38M$160.0K$2.08M$1.48M
    SummaryCapital Expenditure-$1.21M-$1.07M-$2.71M-$14.84M-$11.46M-$11.59M-$13.52M-$10.47M
    Free Cash Flow-$8.88M-$5.56M-$19.90M-$45.49M-$46.03M-$48.76M-$29.49M-$25.05M
    FCF Margin-22.5%-9.7%-21.1%-32.1%-24.6%-23.3%-13.9%-12.2%

    Ratios